Waiver of consent in studies of acute brain injury.      
Was it read? An evaluation of a publication strategy [abstract]      
The way forward: identifying palliative nursing research priorities within a hospice.      
The way of the innovator: notes toward a prehistory of MEDLARS      
Ways of presenting and critiquing action research projects      
Ways to enhance the quality and acceptance of clinical and laboratory studies in homoeopathy      
We are what we say      
"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial.      
We should not pool diagnostic likelihood ratios in systematic reviews      
Weaknesses of Bayesian model averaging for meta-analysis in the study of vitamin E and mortality      
Weaknesses of the mail questionnaire: a methodological study.      
Web-based and mailed questionnaires: a comparison of response rates and compliance.      
Web-based citation management compared to EndNote: options for medical sciences      
Web-based decision support for clinical trial eligibility determination in an international clinical trials network      
Web-based question-answering service of a family physician - the characteristics of queries in a non-commercial open forum.      
Web-based questionnaires: the future in epidemiology?      
Web-based survey attracted age-biased sample with more severe illness than paper-based survey      
A web based survey of healthcare provider and patient interests in the creation of future Internet based cancer information programs [abstract]      
Web citations:going, going, still there [abstract]      
Web designers and web users: influence of the ergonomic quality of the web site on the information search      
Web evaluation at the US National Institutes of Health: use of the American Customer Satisfaction Index online customer survey      
Web navigation structures in cellular phones: the depth/breadth trade-off issue      
Web retrieval systems and the Greek language: do they have an understanding?      
Web sites with misinformation about illicit drugs.      
Webometric analysis of departments of librarianship and information science: a follow-up study      
Week-12 response to therapy as a predictor of week 24, 48, and 96 outcome in patients receiving the HIV fusion inhibitor enfuvirtide in the T-20 versus Optimized Regimen Only (TORO) trials.      
Weighing the evidence: the Canadian experience      
Weight of financial reward in the decision by medical students and experienced healthy volunteers to participate in clinical trials      
Weighted 2x2 kappa coefficients: recommended indices of diagnostic accuracy for evidence-based practice      
Weighting bias in meta-analysis of binary outcomes      
Weighting by inverse variance or by sample size in meta-analysis: a simulation study      
A Welch-type test for homogeneity of contrasts under heteroscedasticity with application to meta-analysis.      
The well-built clinical question: a key to evidence-based decisions      
The well-built clinical question: the key to finding the best evidence efficiently.      
Well child care in the United States: racial differences in compliance with guidelines      
[Well-informed on health matters - How well? The German 'Clearinghouse for Patient Information'--objective, background and methods]      
Well-known signatory does not affect response to a request for information from authors of clinical trials: a randomised controlled trial [abstract]      
Were the outcomes reported in systematic reviews stated in protocols? A systematic review [abstract]      
We've got a groovy thing goin' baby... Or have we? Involving women in clinical trials      
What are the barriers preventing authors from reading written instructions? [abstract]      
What are the characteristics of an application (or team) which are associated with success or failure of an application to the NIHR HTA programme for research funding? [abstract]      
What are the characteristics of good reviews of adverse effects? A qualitative exploration [abstract]      
What are the relative merits of the sources used to identify potential research priorities for the NHS HTA programme?      
What are the reporting and methodological qualities of network meta-analysis? Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
What are the research priorities in the behavioral areas for burn patients?      
What are the research priorities of mental health service users? [editorial]      
What are they looking for on the internet? A pilot study of online informational needs assessment of women with breast cancer in Korea [abstract]      
What are we talking about and who listens? A citation analysis of psychosomatic medicine      
What are we teaching doctors: are national guidelines on respiratory emergencies influencing textbooks? [abstract]      
What blocks the production of Cochrane Reviews in China?      
What British psychiatrists read: questionnaire survey of journal usage among clinicians.      
What can a qualitative review tell us about behavioural interventions for children with autism      
What can dropouts teach us about retention in eating disorder treatment studies?      
What can The Cochrane Collaboration do to support people living in developing countries? [abstract]      
What can we infer from author order in epidemiology? [comment] [see comments]      
What can we learn from a meta-analysis of trials testing the modulation of 5-FU by leucovorin? Advanced Colorectal Meta-analysis Project.      
What can we learn from a prospective trials register? Trends and changes in randomised controlled trials in cancer in the UK [abstract]      
What can we learn from Chinese randomized controlled trials? A systematic review of Chinese venlafaxine studies. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
What can you ask about? The effect on response to a postal screen of asking about two potentially sensitive questions.      
What certainty can there be on how much treatments work: empirical insight from recursive cumulative meta-analyses [abstract]      
What constitutes a "clinical trial"?: A survey of oncology professionals      
What constitutes an update of a systematic review? A survey of the first 377 reviews [abstract]      
What contributions do languages other than English make on the results of meta-analyses?      
What could be expected from systematic reviews on individual patient data? Examples from hypertension treatment [abstract]      
What determines the cost of clinical trials? [abstract]      
What determines whether patients are willing to participate in resuscitation studies requiring exception from informed consent?      
What difference does it make to be treated in a clinical trial? A pilot study.      
What differences are detected by superiority trials or ruled out by noninferiority trials? A cross-sectional study on a random sample of two-hundred two-arms parallel group randomized clinical trials      
What do case-control studies estimate? Survey of methods and assumptions in published case-control research      
What do citation counts count for in the field of addiction? An empirical evaluation of citation counts and their link with peer ratings of quality      
What do evidence-based secondary journals tell us about the publication of clinically important articles in primary healthcare journals?      
What do parents think about enrolling their premature babies in several research studies?      
What do patients and physicians want at the point of care? Preliminary surveys in China [abstract]      
What do peer reviewers do? [see comments]      
What do people at risk for Alzheimer disease think about surrogate consent for research?      
What do primary care nurses and radiation therapists in a Canadian cancer centre think about clinical trials?      
[What do reviewers look for in 'original articles' submitted for publication in the Nederlands Tijdschrift voor Geneeskunde? (published errata appear in Ned Tijdschr Geneeskd 1996 Dec 14;140(50):2540 and 1996 Dec 28;140(52):2652)]      
What do test-treat trials measure? Poster presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]      
'What do they know about it?' How the North Carolina public views cancer clinical trials: implications for primary care doctors      
What do we know about how to do audit and feedback? Pitfalls in applying evidence from a systematic review.      
What do we know about interpretation and application of test accuracy measures? Oral presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
What do we mean by a statistical model?      
What do we mean by web-based learning? A systematic review of the variability of interventions      
What do web users do? An empirical analysis of web use      
What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?      
What does it mean to involve consumers successfully in NHS research? A consensus study.      
What does review of effectiveness of health promotions tell us? [abstract]      
"What does this mean?". How Web-based consumer health information fails to support information seeking in the pursuit of informed consent for screening test decisions      
What else is new? An historical excursion      
What errors do peer reviewers detect, and does training improve their ability to detect them?      
What evidence exists for work-related injury prevention and management? Analysis of an occupational therapy evidence database (OTseeker).      
What evidence should be used in preparing consumer health information? [abstract]      
What evidence, whose evidence?: Physical therapy in New York State's clinical practice guideline and in the lives of mothers of disabled children.      
What exercise and sport scientists don't understand      
What factors are important to parents making decisions about neonatal research?      
What factors influence available trial evidence: the epidemiology of research data on the treatment of osteoarthritis of the knee joint [abstract]      
What factors predict original research citation rates? Analysis of media reports, editorials, guidelines and reviews of Rituximab for non-Hodgkins lymphoma (NHL; 1997-2003). Poster presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]      
What happens to rejected manuscripts? [abstract]      
What happens to study dropouts? The VA Epilepsy Cooperative Study Group. [abstract]      
What happens to the manuscripts that have not been accepted for publication in Occupational and Environmental Medicine?      
What happens when journals move from print to electronic only? [abstract]      
What has been learned from measuring health-related quality of life in clinical oncology      
What have we learnt from Vioxx?      
What influences family physicians' cancer screening decisions when practice guidelines are unclear or conflicting?      
What influences participation in clinical trials in palliative care in a cancer centre?      
What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies.      
What influences the choice of assessment methods in health technology assessments? Statistical analysis of international health technology assessments from 1989 to 2002      
What input errors do you experience? Typing and pointing errors of mobile Webusers      
What is a ''good'' randomised controlled trial? [abstract]      
What is a rapid review? Oral presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
[What is Evidence-Based in Visceral Surgery?]      
What is meant by intention to treat analysis? Survey of published randomised controlled trials      
What is meant by modified intention to treat? Investigating randomised controlled trials [abstract]      
What is missing from descriptions of treatment in trials and reviews?      
What is newsworthy? Longitudinal study of the reporting of medical research in two British newspapers      
What is publication? Cross references to updates of systematic reviews should be published.      
What is 'quality?': a systematic review of criteria from existing resource-evaluation instruments [abstract]      
What is really known about psychological alterations produced by psychiatric drugs?      
What is the added benefit of including case series in systematic reviews? [abstract]      
What is the cost of getting the price wrong?      
What is the dividend of including non-randomised data in systematic reviews? A case study of tension-free vaginal tape (TVT) for treatment of urinary stress incontinence in women.      
[What is the effect of placebo interventions? A systematic review of randomized clinical trials with placebo treated and untreated patients]. [Danish]      
What is the evidence for parenting interventions offered in a Canadian community?      
What is the fate of abstracts presented at the Annual Meeting of the Society for Medical Decision Making? [abstract]      
What is the "golden standard" for assessing population-based interventions?--problems of dilution bias [see comments]      
What is the methodologic quality of human therapy studies in ISI surgical publications?      
What is the minimum clinically important difference (MCID) required to introduce a new treatment into obstetrical practice? Survey of Canadian obstetricians [abstract]      
What is the point of databases of reviews for dermatology if all they compile is "insufficient evidence"?      
What is the probability that new cancer treatments are better than standard treatments? [abstract]      
What is the quality of drug therapy clinical practice guidelines in Canada?      
What is the quality of reporting in weight loss intervention studies? A systematic review of randomized controlled trials.      
What is the quality of the economic information provided in promotional material for family practitioners? The case of proton pump inhibitors in the United Kingdom [abstract]      
What is the quality of the implemented meta-analytic procedures in chronic pain treatment meta-analyses?      
What is the quality of the reporting of research ethics in publications of nursing home research? [review]      
What is the role of public trials registers in Cochrane Systematic Reviews? Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
What is the study design? [abstract]      
What is the value added of patient reported outcomes relative to physician rated symptom assessments? [abstract]      
What is the value of collecting detailed costing data in clinical trials? [abstract]      
What is the value of NIHR HTA Programme funded research in informing UK health care funding decisions [abstract]      
What is this thing called "randomise"?      
What is transparent about the French and Scottish approach to single technology assessment (STA)? [abstract]      
What leads Indians to participate in clinical trials? A meta-analysis of qualitative studies      
What lies behind averages and significance of citation indicators in different disciplines?      
What makes a clinical trial report helpful? A preliminary analysis of rheumatologists' judgements.      
What makes a good reviewer and a good review for a general medical journal?      
What makes an author? A comparison between what authors say they did and what editorial guidelines require [abstract]      
What makes an author? The views of authors, editors, reviewers, and readers [abstract]      
What makes clinical research ethical?      
What may alter the conclusions of reviews?      
What meta-analyses have and have not taught us about psychotherapy effects: a review and future directions      
What methods do trials use to collect adverse data? [abstract]      
What modifications are made in studies reviewed by the United States Food and Drug Administration for medical device approval?Oral presentation at the 17th Cochrane Colloquium; 2009 Oct 11-14, Singapore [abstract]      
What motivates British parents to consent for research? A questionnaire study.      
What outcomes matter to patients: a physician-researcher point of view.      
What parents think about being approached about children's trials, how this differs from what practitioners expect, and what this tells us about enhancing recruitment [abstract]      
What patients say about medical research      
What patients want: consumer involvement in the design of a randomized controlled trial of routine oxygen supplementation after acute stroke.      
What predicts patient (pt) understanding regarding cancer clinical trials (CCT)? [abstract]      
What predicts patients' interest in the internet as a health resource in primary care in England?      
What pregnant women want to know: a comparison of client and provider perceptions      
What proportion of dermatological patients receive evidence-based treatment?      
What proportion of patients refuse consent to data collection from their records for research purposes?      
What proportion of primary psychiatric interventions are based on evidence from randomised controlled trials?      
What proportion of reviewers request anonymous peer review and what are their reasons? [abstract]      
What should be done to tackle ghostwriting in the medical literature?      
What should be included in meta-analyses? An exploration of methodological issues using the ISPOT meta-analyses [review]      
What the Index Medicus indexes, and why      
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of rare events      
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data      
What to do with non 2 x 2 data from a diagnostic systematic review? An example from a review on identifying the seizure focus in patients with epilepsy [abstract]      
What use are qualitative methods in randomised trials? [abstract]      
What value health?: A review of health state values used in early technology assessments for NICE      
What we research: survey of American Association of Neurological Surgeons and Congress of Neurological Surgeons member publications      
What works?: selectivity models and meta-analysis      
What would Archie Cochrane have said?      
Whatever happened to abstracts from different sections of the association for research in vision and ophthalmology?      
Whatever happened to NSC? An analysis of clinical results of discontinued anticancer agents.      
Whatever happened to the t-test?      
What's in a NAME? Clinical trial acronyms and research impact [abstract]      
What's new in psoriasis? Analysis of the clinical significance of systematic reviews on psoriasis published in 2007 and 2008      
The 'What's new' section in Cochrane reviews updated in 2007. Oral presentation at the 16th Cochrane Colloquium: Evidence in the era of globalisation; 2008 Oct 3-7; Freiburg, Germany [abstract]      
What's the basis for treating infections your way? Quality assessment of review articles on the treatment of urinary and respiratory tract infections in older people. [Review]      
What's the point of evaluating effectiveness? Perspectives from a low income setting. Oral presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]      
What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes      
What's the score? Evaluating students' MEDLINE searches [abstract]      
What's the story?: The Cochrane Library publicity, global media coverage and author experience. Oral presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
What's the use of citation? Citation analysis as a literature topic in selected disciplines of the social sciences      
What's time got to do with it? Inattention to duration in interpretation of survival graphs.      
When and how to assess fast-changing technologies: a comparative study of medical applications of four generic technologies      
When and how to update systematic reviews      
When and how to update systematic reviews: a methodological systematic review [abstract]      
When are randomised trials unnecessary? Picking signal from noise.      
When are summary ROC curves appropriate for diagnostic meta-analyses?      
When assessment results are contrary to practice: postmenopausal hormone therapy and Finnish experts [abstract]      
When authorship fails. A proposal to make contributors accountable. [erratum appears in JAMA 1998 Jan 7;279(1):22].      
When can odds ratios mislead?      
When can research conducted elsewhere be useful here? Perceptions of local applicability and transferability. Oral presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]      
When can we conclude that treatments or programs ''don't work''?      
When can we trust 'early' statistically significant treatment effect estimates in cumulative cardiology meta-analyses? - a simulation study. Oral presentation at the Joint Cochrane and Campbell Colloquium; 2010 Oct 18-22; Keystone, Colorado, USA [abstract]      
When do control rates correlate with treatment effects?      
When do indirect and mixed treatment comparisons result in invalid findings? A graphical explanation. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
When does an updated meta-analysis have enough content to justify re-reading? [abstract]      
When epidemiology meets policy: controversies in translating evidence-based cancer screening decisions to the media, policy makers and clinicians [abstract]      
When epidemiology meets the Internet: web-based surveys in the Millennium Cohort Study      
When free condoms and spermicide are not enough: barriers and solutions to participant recruitment to community-based trials.      
When intraclass correlation coefficients go awry: a case study from a school-based smoking prevention study in South Africa      
When is a case-control study not a case-control study?      
When is a search not a search? A comparison of searching the AMED complementary health database via EBSCOhost, OVID and DIALOG      
When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?      
When "no" might not quite mean "no"; the importance of informed and meaningful non-consent: results from a survey of individuals refusing participation in a health-related research project.      
When others decide: reasons for allowing patients with Alzheimer's disease to participate in nontherapeutic research.      
When placebo controlled trials are essential and equivalence trials are inadequate [see comments]      
When should a placebo be used in surgical trials? [abstract]      
When should potentially false research findings be considered acceptable?      
When should randomization to untreated control groups stop? [abstract]      
When small degrees of bias in randomized trials can mislead clinical decisions: an example of individualizing preventive treatment of upper gastrointestinal bleeding      
When to base clinical policies on observational versus randomized trial data. [Review]      
When to stop a clinical trial [see comments]      
When to stop an ongoing trial: the case of Adjuvant Chemotherapy on Colon Cancer (ACCC) [abstract]      
When was a "negative" clinical trial big enough? How many patients you needed depends on what you found      
Where and how to find data on safety: What do systematic reviews of complementary therapies tell us? Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
Where and how to find information on ethical issues for health technology assessments [abstract]      
Where are authors registering clinical trials? [abstract]      
Where are the high-quality, clinically relevant studies published? [abstract]      
Where are the systematic reviews in transfusion medicine? A study of the transfusion evidence base      
Where do completed trials come from? [abstract]      
Where do Israeli scientists publish?      
Where does economics fit in? A review of economics in Cochrane Reviews [abstract]      
Where is smoking research published?      
Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review.      
Where is the wisdom? I - A conceptual history of evidence-based medicine      
Where now for meta-analysis?      
Where should the pharmacy researcher look first? Comparing International Pharmaceutical Abstracts and MEDLINE      
Where to identify information on adverse effects for a systematic review: a methodological overview. Poster presentation at the 16th Cochrane Colloquium: Evidence in the era of globalisation; 2008 Oct 3-7; Freiburg, Germany [abstract]      
Where to publish? Some considerations among English-language addiction journals      
Where we publish: an analysis of the publications of German institutes of pathology      
Which are the leading countries in clinical medicine research? A citation analysis (1981-1998)      
Which bibliometric retrieval method is most effective for general practitioners? Teaching the Index Medicus and Medline on CD-ROM in post-graduate courses for general practitioners [abstract]      
Which coding system for therapeutic information [abstract]      
Which countries publish in important anesthesia and critical care journals?      
Which database sources are our HTA-reports based on? Assessment of where included articles were found [abstract]      
Which databases should we search to identify diagnostic test accuracy studies? [abstract]      
Which diseases and exposures are typically examined in case-control studies?      
Which electronic resources should be searched to identify RCTs for systematic reviews: a systematic overview of the literature [abstract]      
Which guidelines can we trust?: Assessing strength of evidence behind recommendations for clinical practice      
Which journals do primary care physicians and specialists access from an online service?      
Which layout do you prefer? An analysis of readers' preferences for different typographic layouts of structured abstracts      
Which literature retrieval method is cost effective? Teaching the Index Medicus/Medline in postgraduate courses for family physicians [abstract]      
Which literature retrieval method is most effective for GPs?      
Which medical journals have the greatest impact?      
Which meta-analysis model best fits my diagnostic test data? Use of model fit statistics. Oral presentation at the 16th Cochrane Colloquium: Evidence in the era of globalisation; 2008 Oct 3-7; Freiburg, Germany [abstract]      
Which patients will be lost to follow-up? The VA Epilepsy Cooperative Study Group [abstract]      
Which resources of information are used in HTA reports? [abstract]      
Which resources should be used to identify RCT/CCTs for systematic reviews: a systematic review.      
Which review group does this title belong to? [abstract]      
Which treatment for childhood acute lymphoblastic leukaemia in second remission?      
[While science grows and the number of libraries decreases, what will happen to information? (Decrease of medical journals in Hungary)]      
Who are the peer reviewers and how much do they review?      
Who are we blinding? A systematic review of blinded clinical trials      
Who are we missing? Area deprivation and survey participation      
Who benefits from medical interventions? Treating low risk patients can be a high risk strategy      
Who benefits from peer review? An analysis of the outcome of 100 requests for review by Plastic and Reconstructive Surgery.      
Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).      
Who checks what in the divided responsibilities of editors and authors?      
Who controls the placebo? Introducing a Placebo Quality Checklist for pharmacological trials      
Who do Cochrane reviewers believe they are writing for?      
Who doesn't authorize the linking of survey and administrative health data? A general population-based investigation      
Who enrolls onto clinical oncology trials? A radiation Patterns Of Care Study analysis.      
[Who finances medical research in Chile?]      
Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.      
Who is listening? A qualitative study of Cochrane podcast users. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
WHO leads global effort on systematic reviews.      
Who participates in bereavement research? A review and empirical study.      
Who pays for published research?      
Who profits most from a guideline based treatment for advanced breast cancer? [abstract]      
Who refuses enrollment in cardiac clinical trials?      
Who reviews the reviewers? Feasibility of using a fictitious manuscript to evaluate peer reviewer performance      
Who says yes? Identifying selection biases in a psychosocial intervention study of multiple sclerosis      
Who searches the internet for health information?      
Who seeks genetic susceptibility testing for Alzheimer's disease? Findings from a multisite, randomized clinical trial.      
Who shall quit? Comparison of volunteer and population-based recruitment in two minimal-contact smoking cessation studies.      
Who starts treatment: engagement in the NIDA Collaborative Cocaine Treatment Study.      
WHO systematic review of maternal mortality and morbidity: methodological issues and challenges      
Who understands? A survey of 25 words or phrases commonly used in proposed clinical research consent forms      
Who understands? II: A survey of 27 words, phrases, or symbols used in proposed clinical research consent forms      
Who wants to join preventive trials? - Experience from the Estonian Postmenopausal Hormone Therapy Trial.      
Who will adhere? Key issues in the study and prediction of adherence in randomized controlled trials      
Who will consent to emergency treatment trials for subarachnoid hemorrhage?      
Who will enroll? Predicting participation in a phase II AIDS vaccine trial.      
Who's afraid of the randomised controlled trial? Parents' views of an SLT research study.      
Who's afraid of Thomas Bayes?      
Whose data set is it anyway? Sharing raw data from randomized trials.      
Whose health is it? Views about decision-making and information-seeking from people with HIV infection and their professional carers      
Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells      
Why and how do journalists retract articles? [abstract]      
Why, and how, mixed methods research is undertaken in health services research in England: a mixed methods study.      
Why are clinical trial data difficult to apply to individual patient decision making? Lessons from the asthma literature [abstract]      
Why are ethnic minorities under-represented in US research studies?      
Why are investigations not recommended by practice guidelines ordered at the periodic health examination?      
Why are missing quality of life data a problem in clinical trials of cancer therapy?      
Why are (or are not) patients given the option to enter clinical trials?      
Why are patients in clinical trials of heart failure not like those we see in everyday practice?      
Why are physicians not persuaded by scientific evidence? A grounded theory interview study.      
Why are so many epidemiology associations inflated or wrong? Does poorly conducted animal research suggest implausible hypotheses?      
Why are some meta-analyses more credible than others?      
Why are women underused in the JECH peer review process?      
Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision      
Why current publication practices may distort science.      
Why data bases should not replace randomized clinical trials      
Why did the study fail?      
Why do adolescents with type 1 diabetes and their parents participate in focus groups?      
Why do breast cancer patients decline entry into randomised trials and how do they feel about their decision later: a prospective, longitudinal, in-depth interview study      
Why do case studies on national health research systems matter?: identifying common challenges in low- and middle-income countries      
Why do clinicians and policy makers not always benefit from randomized clinical trials reviews: a case for a well-designed systematic review of the use of biologic agents in rheumatoid arthritis [abstract]      
Why do older people opt-out of research studies? [abstract]      
Why do patients accept or decline randomization? [abstract]      
Why do patients with atrial fibrillation not receive warfarin?      
Why do peer reviewers decline to review? A survey      
Why do peer reviewers decline to review? A survey [abstract]      
Why do systematic reviewers choose paper over electronic (Cochrane ) publication? [abstract]      
Why do they do it? A pilot study towards understanding participant motivation and experience in a large genetic epidemiological study of endometriosis.      
Why do we need some large, simple randomized trials?      
Why do we need systematic overviews of randomized trials?      
Why don't GPs follow guidelines? Increasing our understanding of complex interventions by combining qualitative and quantitative reviews. Oral presentation at the 16th Cochrane Colloquium: Evidence in the era of globalisation; 2008 Oct 3-7; Freiburg, Germany [abstract]      
Why don't health researchers report consumer involvement?      
Why don't patients do their exercises? Understanding non-compliance with physiotherapy in patients with osteoarthritis of the knee.      
"Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial      
Why ethnic minority groups are under-represented in clinical trials: a review of the literature.      
[Why evidence-based medicine? 20 years of meta-analysis] [Spanish]      
Why families enroll and continue participating in pediatric research studies [abstract]      
Why have meta-analyses of randomized controlled trials of the association between non-white-blood-cell-reduced allogeneic blood transfusion and postoperative infection produced discordant results?      
Why healthy subjects volunteer for phase I studies and how they perceive their participation?      
Why is recruitment to trials difficult? An investigation into recruitment difficulties in an RCT of supported employment in patients with severe mental illness      
Why is research from developing countries underrepresented in international health literature, and what can be done about it?      
Why learning to communicate with our patients is so important: using communication to enhance accrual to cancer clinical trials      
Why most discovered true associations are inflated      
Why most published research findings are false.      
Why my disease is important: metrics of disease occurrence used in the introductory sections of papers in three leading general medical journals in 1993 and 2003 [abstract]      
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of head-to-head comparison studies of second-generation antipsychotics.      
Why participate in an Alzheimer's disease clinical trial? Is it of benefit to carers and patients?      
Why patients don't take part in cancer clinical trials: an overview of the literature.      
Why people refuse to make tradeoffs in person tradeoff elicitations: a matter of perspective?      
Why proof of safety is much more difficult than proof of hazard      
Why randomize?      
Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: some explanations and suggestions for future studies      
Why randomized controlled trials fail but needn't: 1. Failure to gain "coal-face" commitment and to use the uncertainty principle.      
Why register clinical trials?--Revisited      
Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issues.      
Why review articles on the health effects of passive smoking reach different conclusions      
Why so many 'RCTSs' were false? A further investigation about ethics review status of the 'RCTs' published in Chinese journals. Poster presentation at the 17th Cochrane Colloquium; 2009 Oct 11-14, Singapore [abstract]      
Why sources of heterogeneity in meta-analysis should be investigated      
Why they want to be treated in clinical trial - fundamental reasons of patient's decision [abstract]      
Why transition from alternation to randomisation in clinical trials was made      
Why use placebos in clinical trials? A narrative review of the methodological literature      
Why were they missed? Randomized controlled trials (RCTs) identified through the MEDLINE Retagging Project but not the US National Library of Medicine (NLM). Poster presentation at the 16th Cochrane Colloquium: Evidence in the era of globalisation; 2008 Oct 3-7; Freiburg, Germany [abstract]      
Why women do not accept randomisation for place of birth: feasibility of an RCT in the Netherlands      
Why would physicians undervalue reviews by the Cochrane Collaboration.      
Will donations to their learned college increase surgeons' participation in surveys? A randomized trial.      
Will publication bias vanish in the age of online journals?      
William Gemmell Cochran: the influence of Rothamsted and designed experiments on his research      
Willingness and competence of depressed and schizophrenic inpatients to consent to research.      
Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand      
Willingness of ischemic stroke patients to donate DNA for genetic research: a systematic review      
Willingness of minorities to participate in biomedical studies: confirmatory findings from a follow-up study using the Tuskegee Legacy Project Questionnaire.      
Willingness of older people with cancer to participate in cancer clinical trials is not a barrier to accrual [abstract]      
Willingness of pregnant women and clinicians to participate in a hypothetical randomised controlled trial comparing vaginal delivery and elective caesarean section      
The willingness of women to participate in a long-term trial of hormone replacement therapy: a qualitative study using focus groups.      
Willingness to accept risk in the treatment of rheumatic disease      
Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.      
Willingness to participate as research subjects: Blacks vs Puerto Rican Hispanics vs. Whites [abstract]      
Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.      
Willingness to participate in cancer screenings: blacks vs whites vs Puerto Rican Hispanics      
Willingness to participate in cardiac trials.      
Willingness to participate in clinical treatment research among older African Americans and Whites      
Willingness to participate in complementary and alternative medicine clinical trials among patients with craniofacial disorders      
Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE.      
Willingness to participate in HIV vaccine trials: the impact of trial attributes.      
Willingness to participate in preventive HIV vaccine trials in a community-based cohort in south western Uganda      
Willingness to participate in South African HIV vaccine trials--concerns of medical professionals in the Western Cape      
Willingness-to-pay for a population program aimed at reducing dietary salt in Denmark.      
Willingness to volunteer in future preventive HIV vaccine trials: issues and perspectives from three U.S. communities.      
Withdrawal censoring and the sequential logrank procedure      
''Withdrawn from market'' - how comprehensive and accessible is the evidence-base for medicinal products withdrawn due to safety concern? [abstract]      
Withholding consent to participate in clinical trials: decisions of pregnant women.      
Withholding research results in academic life science. Evidence from a national survey of faculty      
Withholding unfavourable results in drug company sponsored clinical trials      
Withholding unfavourable results in drug company sponsored clinical trials [letter]      
Within trial variation--a false trail? [comment] [see comments]      
Women and willingness to participate in clinical trials: results from a hypothetical randomized control trial [abstract]      
Women as participants in cardiovascular trials [abstract]      
Women authors of surgical research.      
Women, older persons, and ethnic minorities: factors associated with their inclusion in randomised trials of statins 1990 to 2001.      
Women participants in research: assessing progress      
Women's attitudes to hormone replacement therapy in the aftermath of the Women's Health Initiative study.      
Women's decision making about whether or not to use breast cancer chemoprevention.      
Women's evaluations of their experience in a multicenter randomized controlled trial of intrapartum fetal pulse oximetry (The FOREMOST Trial).      
Women's experiences of participating in the magpie trial: a postal survey in the United Kingdom      
Women's feedback on a chemopreventive trial for cervical dysplasia      
The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions      
Women's participation in AIDS Clinical Trials Group (ACTG) trials in the USA: enough or still too few?      
Women's use of the Internet for health information: the impact of selected demographic and health variables [abstract]      
Women's views and experiences of a patient preference trial in surgery: a qualitative study of the CARPET1 Trial      
Woods and Russell, Hill, and the emergence of medical statistics      
Word frequency analysis of over a million words to support the development of search strategies on 'health-related values'. Poster presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
Wording GRADEd evidence statements and recommendations. Oral presentation at the 19th Cochrane Colloquium; 2011 Oct 19-22; Madrid, Spain [abstract]      
Worked examples of alternative methods for the synthesis of qualitative and quantitative research in systematic reviews.      
Workflow to improve patient recruitment for clinical trials within hospital information systems - a case-study.      
Workup bias in prediction research      
World Medical Association declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects      
The world wide wait: effects of delays on user performance      
A worldwide assessment of medical journal editors' practices and needs--results of a survey by the World Association of Medical Editors      
Worldwide clinical interventional studies on leading causes of death: a descriptive analysis      
Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.[erratum appears in Am J Reprod Immunol 1994 Oct;32(3):255]      
Would you drop your membership? Professional organization members' reaction to open access [abstract]      
Writing the conclusions: how do bullet-points help?      
Writing to authors of systematic reviews elicited further data in 17% of cases      
Written informed consent for participation in a study and reduction in consent rate.      
Written parental consent in school-based HIV/AIDS prevention research.      
Written patient information: a review of the literature.      
www.iiresearch.org: An internet platform for investigator initiated randomized clinical trials [abstract]